Swallowable drug delivery device and method of delivery
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-037/00
A61K-009/22
A61M-005/32
A61K-038/26
A61M-005/20
A61K-038/28
A61K-038/29
A61K-038/27
A61K-031/155
A61M-031/00
출원번호
US-0970446
(2013-08-19)
등록번호
US-8852151
(2014-10-07)
발명자
/ 주소
Imran, Mir
출원인 / 주소
Rani Therapeutics, LLC
대리인 / 주소
Wilson Sonsini Goodrich & Rosati
인용정보
피인용 횟수 :
30인용 특허 :
27
초록▼
Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Some embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. The device compri
Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Some embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. The device comprises a capsule sized to be swallowed and pass through the intestinal tract. The capsule can include at least one guide tube, one or more tissue penetrating members positioned in the guide tube, a delivery member, an actuating mechanism and a release element. The release element degrades upon exposure to various conditions in the intestine so as to release and actuate the actuating mechanism. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
대표청구항▼
1. A swallowable device for inserting a therapeutic agent preparation into an intestinal wall of a patient's intestinal tract, the device comprising: a swallowable capsule sized to pass through the intestinal tract, the capsule having a capsule wall;at least a portion of the capsule wall comprising
1. A swallowable device for inserting a therapeutic agent preparation into an intestinal wall of a patient's intestinal tract, the device comprising: a swallowable capsule sized to pass through the intestinal tract, the capsule having a capsule wall;at least a portion of the capsule wall comprising a material or coating which protects the capsule from degradation in the stomach and degrades in response to a pH in the intestinal tract;a tissue penetrating member including the therapeutic agent preparation disposed in the capsule; andan expandable member for advancing the tissue penetrating member from the capsule into the intestinal wall of the patient responsive to a selected pH in the intestinal tract, the expandable member expanded by a chemical reaction. 2. The swallowable device of claim 1, wherein the expandable member is expanded by a gas generating reaction. 3. The swallowable device of claim 1, wherein a reactant for the chemical reaction is contained within the expandable member. 4. The swallowable device of claim 1, wherein the expandable member comprises at least a first portion and a second portion, the portions separated by a separation means, the first portion containing, a liquid, the second portion containing a reactant, upon mixing, the reactant and liquid produce a gas which expands the expandable member. 5. The swallowable device of claim 4, wherein the separation means comprises a degradable valve which degrades and opens in response to contact with intestinal fluids. 6. The swallowable device of claim 1, wherein the intestinal wall is the wall of the small intestinal tract and the pH is a pH in the small intestine. 7. The swallowable device of claim 1, further comprising a delivery member operably coupled to at least one of the expandable member or the tissue penetrating member. 8. The swallowable device of claim 7, wherein the delivery member comprises a piston. 9. The swallowable device of claim 8, wherein the delivery member is advanced by expansion of the expandable member. 10. The swallowable device of claim 9, wherein the expandable member comprises a balloon. 11. The swallowable device of claim 7, wherein the delivery member is advanced by a gas pressure. 12. The swallowable device of claim 11, wherein the intestinal wall is the wall of the small intestinal tract and the gas pressure is sufficient to advance the tissue penetrating member into the wall of the small intestine. 13. The swallowable device of claim 11, wherein the gas pressure is developed inside a container. 14. The swallowable device of claim 13, wherein the container comprises the expandable member. 15. The swallowable device of claim 14, wherein the expandable member comprises a balloon. 16. The swallowable device of claim 14, wherein the expandable member comprises at least a first portion and a second portion, the portions separated by a separation means, the first portion containing a liquid, the second portion containing a reactant, upon mixing, the reactant and liquid produce a gas which generates the gas pressure to advance the delivery member. 17. The swallowable device of claim 16, wherein the separation means comprises a degradable valve. 18. The swallowable device of claim 17, wherein the valve degrades and opens in response to contact with intestinal fluids.
Wright Jeremy C. (Los Altos CA) Eckenhoff James B. (Los Altos CA) Maruyama Frederick H. (San Jose CA) Peery John R. (Stanford CA), Delivery system comprising means for controlling internal pressure.
Lewkowicz,Shlomo; Gat,Daniel; Kraizer,Yehudit; Gilad,Zvika; Leuw,David; Meron,Gavriel; Glukhovsky,Arkady, Device and method for examining a body lumen.
Hugemann Berhhard (Frankfurt am Main DEX) Schuster Otto (Bad Soden DEX), Device for the release of substances at defined locations in the alimentary tract.
Pasricha Pankaj J. (Columbia MD) Kalloo Anthony N. (Glenndale MD), Device for treating gastrointestinal muscle disorders and other smooth muscle dysfunction.
Yokoi,Takeshi; Takizawa,Hironobu; Segawa,Hidetake; Adachi,Hideyuki, Encapsulated medical device and method of examining, curing, and treating internal region of body cavity using encapsulated medical device.
Lehmann Grard (Neuville de Poitou FRX) Metais Jol (Monts Sur Guesnes FRX) Meunier Jean-Francois (Noisy le Grand FRX) Gautier Jean-Philippe (Ozoir la Ferriere FRX), Implantable drug-dispensing capsule and system facilitating its use.
Truex Buehl E. (Glendora CA) Gibson Scott R. (Granada Hills CA) Weinberg Alvin H. (Moorpark CA), Implantable medical device having shielded and filtered feedthrough assembly and methods for making such assembly.
Brister, Mark C.; Quintana, Nelson; Patel, Kaushik A.; Drake, Neil R.; Llevares, Antonio C.; Markovic, Dubravka; Rasdal, Andrew P.; VandenBerg, Amy D. L., Intragastric device.
Saffran Murray (Toledo OH) Neckers Douglas C. (Perrysburg OH), Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointest.
Nicolaides Ernest D. (Ann Arbor MI) Tinney Francis J. (Ann Arbor MI) Kaltenbronn James S. (Ann Arbor MI) DeJohn Dana E. (Ann Arbor MI) Lunney Elizabeth A. (Ann Arbor MI) Roark W. Howard (Ann Arbor MI, Modified tripeptides.
Eckenhoff ; deceased James B. ; Holladay Leslie A. ; Leonard ; Jr. John Joseph ; Leung Iris K. M. ; Tao Sally A. ; Magruder Judy A. ; Carr John P. ; Wright Jeremy, Peptide/protein suspending formulations.
Imran, Mir A.; Herrmann, Peter; Syed, Baber; Williams, Timothy H.; Ong, Chang Jin; Method, Greg, Device, system and methods for the oral delivery of therapeutic compounds.
Imran, Mir, Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.